Hyperthermic intraperitoneal chemotherapy (HIPEC) is a key component of treatment in non-gynecologic peritoneal surface malignancies. As many as 10-15% of patients with a gastrointestinal primary malignancy will present with carcinomatosis. Maximal cytoreductive surgery directly affects the prognosis of patients. The routine inclusion of hysterectomy with bilateral salpingo-oophorectomy during these procedures optimizes cytoreduction despite negative pre-operative imaging and findings at the time of surgery. In this case series, we review twenty non-gynecologic cancer patients who underwent cytoreductive surgery with concurrent hysterectomy and bilateral salpingo-oophorectomy and HIPEC at our institution.
Digital Object Identifier (DOI)
Riggs, McKayla J.; Lin, Miranda; Kim, Joseph; Pandalai, Prakash; and Dietrich, Charles S. III, "Concurrent Hysterectomy and Bilateral Salpingo-Oophorectomy during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-Gynecologic Cancers" (2020). Obstetrics and Gynecology Faculty Publications. 26.